Fifty-for-50-banner-2_fifty-for-50-banner_fifty-for-50-banner

Celebrating Regulatory Trailblazers

In 2026, we’re celebrating 50 years of regulatory affairs by recognizing 50 outstanding regulatory professionals.

50-for-50_Kate Stockman

This Week's Recognition: Kate Stockman

Over more than 20 years in regulatory affairs, Kate Stockman shaped today’s regulatory environment by developing creative strategies, successfully engaging with health authorities, and delivering global product approvals across many product categories. Kate has served as the co-chair of the RAPS Euro Convergence Planning Committee for the past two years and is a member of the RAPS European Council.

Fifty for 50 Recognitions

50-for-50-headshots_Peter-Barton-Hutt-1

Peter Barton Hutt

As FDA’s chief counsel from 1971-1975, Peter overturned the agency’s long-held view that it had no authority to issue binding, substantive regulations. Using this newfound rulemaking authority, Peter created the FDA Regulatory Letter (now the Warning Letter), nutrition labeling requirements, Freedom of Information Act regulations, and other elements core to the regulatory profession today.
50-for-50-headshots_Kamana-Singh

Kamana Singh

Kamana Singh has spent almost two decades building regulatory systems that protect patients, empower teams, and support the development of innovative therapies. Across her career, she has led complex global labeling programs and supported organizations through pivotal regulatory milestones. As a speaker, mentor, author, and RAPS chapter leader, she has advanced the regulatory profession and supported regulatory affairs professionals as they navigate their way through the profession.
50-for-50-headshots_Frederike-Brühschwein-Mandic

Frederike Brühschwein Mandic

Frederike has spent more than 15 years in the medical device field developing and executing global regulatory strategies, leading and mentoring multi-disciplinary teams, and consulting for startups and established global corporations. She is a member of the RAPS Euro Convergence Planning Committee and has her RAC-Devices credential.
50-for-50_Janet-Michener-Whipple

Janet Michener Whipple

Over 35 years working in the regulation of medical devices, IVDs, and combination products, Janet Michener Whipple has overseen large regulatory and quality projects for medical device and IVD firms, led activities to remediate design controls, CAPA and MDR reporting processes after receipt of FDA Warning Letters and untitled letters, and more. Janet was the founding chair of the RAPS Southern California Local Networking Group and has her RCC-IVDR credential.
50-for-50_Heena-Thakkar

Heena Thakkar

Heena Thakkar has spent her young regulatory career as a passionate promoter for upskilling and mentorship in regulatory affairs, first in roles at medical device companies in the US and India and now as an independent consultant. She holds her RCC-MDR credential and is a regular contributor on Regulatory Exchange (RegEx), the RAPS online member community.
50-for-50_Silu-Zhang

Silu Zhang

Silu Zhang is a global regulatory leader who has shaped regulation through standards development and sustained engagement across regulators, industry, and academia. Her work has strengthened regulatory science and helped build more efficient, internationally aligned regulatory frameworks, including by participating in regulatory revisions that removed after-sales service organization requirements from NMPA registration certificates in China. She is a member of the RCC-IVDR Committee and holds the RAC-Devices, RCC-MDR , and RCC-IVDR credentials.
50-for-50_James-Wabby

James Wabby

James is the chair of the RAPS Southern California Local Networking Group and is an alum of the RAPS Kellogg Executive Development Program. Over more than 25 years in regulatory and quality, James has driven regulatory innovation across combination products, medical devices, digital medicine, and complex generics. James has contributed to RAPS Fundamentals of Medical Device Regulations: A Global Perspective and has been a speaker at RAPS Convergence, the RAPS Global Regulatory Strategy Conference, and other regulatory and quality events.
50-for-50_Linda-Bowen

Linda Bowen

Over her 30 years as a RAPS member, Linda has served the regulatory profession on countless committees, and as a RAPS Board member, author, chapter leader, presenter, mentor, and more. She is the editor of the newly released Regulatory Intelligence, Reimagined, and currently serves on the RAPS Institute Board.

50-for-50_Kevin-Randall

Kevin Randall

For over 30 years, Kevin has served as a quality systems instructor, mentor, and teacher for the regulatory and quality community. He has been a prolific contributor to Regulatory Exchange, RAPS’ online member community, where his comments have helped countless professionals navigate the complicated scenarios innate to a career in regulatory and quality. He holds the RAC-US, RAC-EU, RAC-Canada, and RCC-MDR credentials.

50-for-50_Katelin-Henninger

Katelin Henninger

Since she started her career in regulatory and quality in 2018, Katelin has overseen regulatory submissions and approvals while leading teams in both medical devices and pharmaceuticals. Katelin contributed to Fundamentals of Medical Device Regulations: A Global Perspective and helped create the RAPS Greater Cincinnati Local Networking group in 2025. She holds the RAC-Device and RCC-MDR credentials.

50-for-50_Ludger-Moeller

Ludger Moeller

Over three decades of experience in regulatory compliance, Ludger has founded multiple organizations dedicated to supporting medical device companies throughout the complex regulatory process. He has participated as a member of the European Union’s Medical Device Coordination Group, is a founding member of the RAPS Germany Chapter, and has been a regular speaker at international conferences and panels.

50-for-50_Chris-Whalley

Chris Whalley

Chris Whalley is shepherding the future of regulatory affairs as RAPS Convergence Planning Committee Chair and contributing to books like Regulatory Intelligence Reimagined. Chris has also served on the RAPS Convergence Planning Committee as a member and as vice chair, and currently leads regulatory intelligence activities at Pfizer as their senior director and head of global regulatory intelligence & analysis.

50-for-50_Alberto-Grignolo

Alberto Grignolo

For more than 40 years, Alberto Grignolo has contributed his expertise as a regulatory and drug development professional and corporate executive, including 32 years as a consultant to pharmaceutical and biotechnology companies and driver of a successful worldwide regulatory and drug development consulting business.

50-for-50_Victor-Mencarelli

Victor Mencarelli

For years, Victor Mencarelli has shared his experience as one of our top contributors on Regulatory Exchange (RegEx), the RAPS online member community, where he contributes to discussions that help regulatory affairs professionals learn from his time as a director of global regulatory affairs.

50-for-50_Markus-Poettker

Markus Pöttker

As director of global postmarket surveillance at Smith + Nephew, chair of MedTech Europe’s PS and Vigilance Working Group, and as a member of the EU Medical Device Coordination Group’s Task Forces for Vigilance, PSUR, and postmarket surveillance, Markus Pöttker has navigated complex regulatory realities and advanced the field of postmarket surveillance.

50-for-50_Paul-Brooks

Paul Brooks

Paul Brooks has served the regulatory affairs profession in a way few others have. After more than 20 years at BSI and serving as chair of the RAPS Board of Directors, Paul became the executive director at RAPS in 2016. As our society’s leader, he took RAPS to new heights as we grew our membership to new levels, expanded our global reach, and refined and improved many key initiatives before his retirement in 2020.

50-for-50_Susan Stewart

Susan Stewart

Susan Stewart has shaped regulatory strategy and contributed to innovation across multiple organizations as a leader in regulatory affairs. Susan first worked her way up from associate to vice president of regulatory affairs at Genzyme Corporation, and has worked in leadership roles at Transmolecular, Tokai Pharmaceuticals, Kaleido Biosciences, Frequency Therapeutics, Q23 BIO, Candel Therapeutics, and Rezolute Bio.

Susan has served the profession as a member of the RAPS Board of Directors, the RAPS Fellows Committee, the Rare Disease Company Coalition Board of Directors, and as regulatory advisor to the Termeer Foundation. She has earned her RAC-US and RAC-EU credentials.

50-for-50_Angelina Lisandrelli

Angelina Lisandrelli

Angelina Lisandrelli has served the regulatory affairs profession as an accomplished medical device expert, volunteer, and mentor. During a 15+ year career that began in chemistry, Angelina has developed regulatory strategies, led teams, and built relationships across industry, health authorities, and notified bodies. She is a member of the RAPS Convergence Planning Committee, RAPS Membership Committee, and RAPS Education Committee, and has mentored countless professionals through the RAPS Mentoring Program.

Help us celebrate 50 regulatory trailblazers!

For RAPS' 50th Anniversary, we're shining a spotlight on 50 outstanding regulatory professionals who have contributed broadly in the field. Each selected honoree will be featured in RAPS communication throughout the year. All submissions are reviewed by the Nominating Committee.

Shaping Regulatory Excellence and Innovation since 1976

Back to 50th Anniversary Homepage